CJC-1295 (No DAC): A Research Overview
CJC-1295 (No DAC) is a synthetic analogue of growth-hormone-releasing hormone and a widely researched compound in growth-hormone studies. This overview covers what it is, what the research explores, and why material quality matters. Supplied strictly for research use only.
What is CJC-1295 (No DAC)?
CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH). In preclinical research it is investigated for its role in prompting the pituitary gland to release growth hormone.
DAC vs No DAC
CJC-1295 exists in two research forms. The DAC (Drug Affinity Complex) version is studied for a longer-acting profile, while the No DAC version, also known as Modified GRF 1-29, is shorter-acting and is studied for a more pulse-like release pattern in laboratory models. Claripep supplies the No DAC form.
Often researched with Ipamorelin
CJC-1295 and Ipamorelin act on different pathways and are frequently studied together. See our CJC-1295 vs Ipamorelin comparison and the combined Ipamorelin and CJC-1295 overview.
Why purity and verification matter
Every Claripep batch of CJC-1295 (No DAC) is independently tested by Janoshik for HPLC purity and identity, with the certificate of analysis published. See how we test, the certificates of analysis, or browse CJC-1295 (No DAC).
Research use only. This material is intended solely for laboratory and research purposes, is not for human or animal consumption, and no therapeutic or dosing claims are made.
